carbamazepine has been researched along with Dysarthosis in 14 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Excerpt | Relevance | Reference |
---|---|---|
"In a case of acute intoxication produced by carbamazepine overdose ataxia and cyclic coma were the salient features." | 3.67 | Carbamazepine poisoning: a case report. ( Manni, R; Maurelli, M; Sandrini, G; Savoldi, F; Tartara, A, 1986) |
"Multiple sclerosis is a common inflammatory demyelinating disease of the central nervous system." | 1.62 | [Paroxysmal dysarthria and ataxia - unusual MS manifestation]. ( Morar, F; Papastergios, C; Schiopu-Mariean, BL; Shaker, A, 2021) |
"Treatment with carbamazepine resulted in the complete reversal of the paroxysmal ataxia and dysarthria." | 1.40 | Paroxysmal ataxia and dysarthria in multiple sclerosis. ( Batocchi, AP; Capone, F; Iorio, R; Plantone, D, 2014) |
"Paroxysmal dysarthria is an unusual condition characterised by brief episodes of dysarthria with the sudden onset and frequent recurrence." | 1.39 | Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion. ( Bigliardi, G; Chiari, A; Codeluppi, L; Meletti, S, 2013) |
"Paroxysmal dysarthria-ataxia syndrome (PDA) is a rare neurological disorder that can be either primary or symptomatic of acute neurological dysfunction." | 1.36 | Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. ( Anheim, M; Boulay, C; Flamand-Rouvière, C; Heran, F; Marcel, C; Mari, I; Masnou, P; Roze, E; Tranchant, C, 2010) |
"Treatment with carbamazepine was effective." | 1.35 | Midbrain lesions and paroxysmal dysarthria in multiple sclerosis. ( Blanco, Y; Compta, Y; Graus, F; Saiz, A, 2008) |
"The diagnosis of ciguatera is based on the typical history of a fishmeal followed by characteristic clinical findings with predominant neurological symptoms, often including dysaesthesiae, besides gastrointestinal disturbances." | 1.31 | [Ciguatera: clinical relevance of a marine neurotoxin]. ( Giess, R; Rieckmann, P; Ruprecht, K, 2001) |
"Carbamazepine was ineffective but temporary clinical and electroencephalographic improvement followed the administration of ACTH." | 1.26 | Periodic ataxia: an unusual non-familial variation with paroxysmal EEG features. ( Braham, J; Sadeh, M; Siegal, T, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (28.57) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Papastergios, C | 1 |
Shaker, A | 1 |
Schiopu-Mariean, BL | 1 |
Morar, F | 1 |
Iorio, R | 1 |
Capone, F | 1 |
Plantone, D | 1 |
Batocchi, AP | 1 |
Codeluppi, L | 1 |
Bigliardi, G | 1 |
Chiari, A | 1 |
Meletti, S | 1 |
Jain, RS | 1 |
Handa, R | 1 |
Vyas, A | 1 |
Prakash, S | 1 |
Nagpal, K | 1 |
Blanco, Y | 1 |
Compta, Y | 1 |
Graus, F | 1 |
Saiz, A | 1 |
Marcel, C | 1 |
Anheim, M | 1 |
Flamand-Rouvière, C | 1 |
Heran, F | 1 |
Masnou, P | 1 |
Boulay, C | 1 |
Mari, I | 1 |
Tranchant, C | 1 |
Roze, E | 1 |
Meila, D | 1 |
Wetter, A | 1 |
Brassel, F | 1 |
Nacimiento, W | 1 |
Berroya, AG | 1 |
McIntyre, J | 1 |
Webster, R | 1 |
Lah, S | 1 |
Sabaz, M | 1 |
Lawson, J | 1 |
Bleasel, AF | 1 |
Bye, AM | 1 |
Braham, J | 1 |
Siegal, T | 1 |
Sadeh, M | 1 |
Ruprecht, K | 1 |
Rieckmann, P | 1 |
Giess, R | 1 |
Wolf, P | 1 |
Zavalishin, IA | 1 |
Nevskaia, OM | 1 |
Niiazbekova, AS | 1 |
ten Berg, JM | 1 |
de Waal, WJ | 1 |
Mauser, HW | 1 |
Tartara, A | 1 |
Manni, R | 1 |
Maurelli, M | 1 |
Sandrini, G | 1 |
Savoldi, F | 1 |
14 other studies available for carbamazepine and Dysarthosis
Article | Year |
---|---|
[Paroxysmal dysarthria and ataxia - unusual MS manifestation].
Topics: Ataxia; Carbamazepine; Dysarthria; Female; Humans; Middle Aged; Multiple Sclerosis | 2021 |
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Dysarthria; Humans; Male; Multiple Sclerosis | 2014 |
Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.
Topics: Adult; Anticonvulsants; Carbamazepine; Demyelinating Diseases; Diagnosis, Differential; Dysarthria; | 2013 |
Clinically isolated syndrome presenting as paroxysmal dysarthria: a rare but typical presentation.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Contrast Media; Demyelinating Diseases; Dysarthria; Fe | 2014 |
Midbrain lesions and paroxysmal dysarthria in multiple sclerosis.
Topics: Anticonvulsants; Ataxia; Carbamazepine; Dysarthria; Female; Humans; Magnetic Resonance Imaging; Male | 2008 |
Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Ataxia; Carbamazepine; Demyelinatin | 2010 |
Intermittent hypoglossal nerve palsy caused by a calcified persistent hypoglossal artery: an uncommon neurovascular compression syndrome.
Topics: Aged; Angiography, Digital Subtraction; Basilar Artery; Calcinosis; Carbamazepine; Carotid Artery, I | 2012 |
Speech and language deterioration in benign rolandic epilepsy.
Topics: Anomia; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Cognition Disorder | 2004 |
Periodic ataxia: an unusual non-familial variation with paroxysmal EEG features.
Topics: Adult; Ataxia; Carbamazepine; Dysarthria; Electroencephalography; Humans; Immunoglobulin A; Immunogl | 1982 |
[Ciguatera: clinical relevance of a marine neurotoxin].
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Ciguatera Poisoning; Diagnosis, Differ | 2001 |
[Non-epileptic fits in multiple sclerosis].
Topics: Ataxia; Carbamazepine; Dysarthria; Humans; Multiple Sclerosis; Pain; Paresthesia; Seizures; Time Fac | 1979 |
[Paroxysmal attacks of dysarthria and ataxia in multiple sclerosis].
Topics: Adult; Ataxia; Carbamazepine; Diagnosis, Differential; Dysarthria; Epilepsy; Humans; Male; Multiple | 1978 |
[Paroxysmal symptoms as initial expression of multiple sclerosis].
Topics: Adult; Carbamazepine; Diplopia; Dysarthria; Female; Gait; Humans; Multiple Sclerosis; Muscle Cramp; | 1992 |
Carbamazepine poisoning: a case report.
Topics: Adolescent; Ataxia; Carbamazepine; Coma; Dysarthria; Female; Hematuria; Humans; Myoclonus; Respirati | 1986 |